Transcatheter closure of paravalvular leaks is a developing, technically challenging alternative to high-risk repeat surgery, with low procedural mortality but variable efficacy.
No takes yet. Share an insight, caveat, or question.
Variable efficacy warrants cautious adoption in select high-risk patients; leaves open need for randomized trials on durability and selection.
Larry Latson (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: